X. Pan

Targeting NEDD8-activating enzyme is a new approach to treat canine diffuse large B-cell lymphoma.

Z. Lu, A. Assumpção, K. W. Marlowe, 2018, Veterinary and comparative oncology.

STAT3 Expression and Activity are Up‐Regulated in Diffuse Large B Cell Lymphoma of Dogs

Z. Lu, M. Pinkerton, A. Assumpção, 2017, Journal of veterinary internal medicine.

MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.

H. Peng, G. Ma, Q. Su, 2019, European review for medical and pharmacological sciences.

LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.

D. You, X. Pan, Z. Qiu, 2020, Neoplasma.

Overexpression of long non-coding RNA SBF2-AS1 promotes cell progression in esophageal squamous cell carcinoma (ESCC) by repressing miR-494 to up-regulate PFN2 expression.

D. You, X. Pan, Qiu-Yin Zhang, 2020, Biology open.

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia(®) ) in tumour-bearing dogs: a phase I dose-finding study.

D. Vail, I. Kurzman, X. Pan, 2016, Veterinary and comparative oncology.

JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B‐Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation

Z. Lu, N. Bollig, G. Kong, 2017, Journal of veterinary internal medicine.